{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:06:50Z","timestamp":1777410410937,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s12010-023-04815-0","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T09:02:17Z","timestamp":1704186137000},"page":"5875-5902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An Integrated Computational Approaches for Designing of Potential Piperidine based Inhibitors of Alzheimer Disease by Targeting Cholinesterase and Monoamine Oxidases Isoenzymes"],"prefix":"10.1007","volume":"196","author":[{"given":"Muhammad","family":"Sarfraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Khurrum","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-7234","authenticated-orcid":false,"given":"Syeda Abida","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Muhammad","family":"Attaullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubashir","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mosab","family":"Arafat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahira","family":"Shamim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muawya","family":"Elhadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahira","family":"Ruby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hafiz Kashif","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"issue":"11","key":"4815_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3390\/diagnostics11112023","volume":"11","author":"A Lau","year":"2021","unstructured":"Lau, A., et al. (2021). Alzheimer\u2019s disease-related metabolic pattern in diverse forms of neurodegenerative diseases. Diagnostics, 11(11), 2023.","journal-title":"Diagnostics"},{"issue":"2","key":"4815_CR2","first-page":"263","volume":"103","author":"A Atri","year":"2019","unstructured":"Atri, A. (2019). The Alzheimer\u2019s disease clinical spectrum: Diagnosis and management. Medical Clinics, 103(2), 263\u2013293.","journal-title":"Medical Clinics"},{"issue":"1","key":"4815_CR3","first-page":"32","volume":"77","author":"DP Perl","year":"2010","unstructured":"Perl, D. P. (2010). Neuropathology of Alzheimer\u2019s disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine: A Journal of Translational and Personalized Medicine, 77(1), 32\u201342.","journal-title":"Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine: A Journal of Translational and Personalized Medicine"},{"issue":"9","key":"4815_CR4","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.jmb.2019.01.018","volume":"431","author":"TJ Huat","year":"2019","unstructured":"Huat, T. J., et al. (2019). Metal toxicity links to Alzheimer\u2019s disease and neuroinflammation. Journal of Molecular Biology, 431(9), 1843\u20131868.","journal-title":"Journal of Molecular Biology"},{"key":"4815_CR5","first-page":"73","volume-title":"Aging and global health","author":"M Jakovljevic","year":"2021","unstructured":"Jakovljevic, M., et al. (2021). Aging and global health (pp. 73\u2013102). Handbook of global health."},{"issue":"4","key":"4815_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","volume":"14","author":"J Jia","year":"2018","unstructured":"Jia, J., et al. (2018). The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide. Alzheimer\u2019s & Dementia, 14(4), 483\u2013491.","journal-title":"Alzheimer's & Dementia"},{"issue":"17","key":"4815_CR7","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.3390\/ijms21175965","volume":"21","author":"TJ Eckroat","year":"2020","unstructured":"Eckroat, T. J., Manross, D. L., & Cowan, S. C. (2020). Merged tacrine-based, multitarget-directed acetylcholinesterase inhibitors 2015\u2013present: Synthesis and biological activity. International Journal of Molecular Sciences, 21(17), 5965.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"4815_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41398-020-00928-w","volume":"10","author":"PJ Fitzgerald","year":"2020","unstructured":"Fitzgerald, P. J., et al. (2020). The cholinesterase inhibitor donepezil has antidepressant-like properties in the mouse forced swim test. Translational Psychiatry, 10(1), 255.","journal-title":"Translational Psychiatry"},{"key":"4815_CR9","doi-asserted-by":"publisher","first-page":"652494","DOI":"10.3389\/fnbeh.2021.652494","volume":"15","author":"FT Crews","year":"2021","unstructured":"Crews, F. T., et al. (2021). Loss of basal forebrain cholinergic neurons following adolescent binge ethanol exposure: Recovery with the cholinesterase inhibitor galantamine. Frontiers in Behavioral Neuroscience, 15, 652494.","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"2","key":"4815_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2000.2.2\/lschneider","volume":"2","author":"LS Schneider","year":"2022","unstructured":"Schneider, L. S. (2022). A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer\u2019s disease. Dialogues in clinical neuroscience, 2(2), 111\u2013128.","journal-title":"Dialogues in clinical neuroscience"},{"issue":"60A","key":"4815_CR11","first-page":"121","volume":"33","author":".Jha, A., & Singh, A.","year":"2021","unstructured":".Jha, A., & Singh, A. (2021). Cholinesterase inhibitors used for the management of Alzheimer\u2019s disease: A review. Journal of Pharmaceutical Research International, 33(60A), 121\u2013128.","journal-title":"Journal of Pharmaceutical Research International"},{"key":"4815_CR12","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00702-018-1853-9","volume":"125","author":"\u00c9 Sz\u00f6k\u0151","year":"2018","unstructured":"Sz\u00f6k\u0151, \u00c9., et al. (2018). Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson\u2019s disease. Journal of Neural Transmission, 125, 1735\u20131749.","journal-title":"Journal of Neural Transmission"},{"issue":"5","key":"4815_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/13543776.2021.1874344","volume":"31","author":"M Bortolami","year":"2021","unstructured":"Bortolami, M., et al. (2021). Acetylcholinesterase inhibitors for the treatment of Alzheimer\u2019s disease\u2013A patent review (2016\u2013present). Expert Opinion on Therapeutic Patents, 31(5), 399\u2013420.","journal-title":"Expert Opinion on Therapeutic Patents"},{"issue":"6","key":"4815_CR14","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"Z-R Chen","year":"2022","unstructured":"Chen, Z.-R., et al. (2022). Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules, 27(6), 1816.","journal-title":"Molecules"},{"issue":"1","key":"4815_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang, W., et al. (2020). Current and projected future economic burden of Parkinson\u2019s disease in the US. npj Parkinson\u2019s Disease, 6(1), 15.","journal-title":"npj Parkinson's Disease"},{"key":"4815_CR16","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","volume":"57","author":"G Monzio Compagnoni","year":"2020","unstructured":"Monzio Compagnoni, G., et al. (2020). The role of mitochondria in neurodegenerative diseases: The lesson from Alzheimer\u2019s disease and Parkinson\u2019s disease. Molecular neurobiology, 57, 2959\u20132980.","journal-title":"Molecular neurobiology"},{"issue":"4","key":"4815_CR17","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jagp.2020.07.011","volume":"29","author":"J Cummings","year":"2021","unstructured":"Cummings, J. (2021). The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases. The American Journal of Geriatric Psychiatry, 29(4), 375\u2013383.","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"s1","key":"4815_CR18","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.3233\/JPD-202135","volume":"10","author":"B Post","year":"2020","unstructured":"Post, B., et al. (2020). Young onset Parkinson\u2019s disease: A modern and tailored approach. Journal of Parkinson\u2019s Disease, 10(s1), S29\u2013S36.","journal-title":"Journal of Parkinson's Disease"},{"key":"4815_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.gene.2018.04.010","volume":"662","author":"MR Delavar","year":"2018","unstructured":"Delavar, M. R., et al. (2018). Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson\u2019s disease. Gene, 662, 54\u201365.","journal-title":"Gene"},{"issue":"6","key":"4815_CR20","doi-asserted-by":"publisher","first-page":"658","DOI":"10.14219\/jada.archive.2009.0251","volume":"140","author":"AH Friedlander","year":"2009","unstructured":"Friedlander, A. H., et al. (2009). Parkinson disease: Systemic and orofacial manifestations, medical and dental management. The Journal of the American Dental Association, 140(6), 658\u2013669.","journal-title":"The Journal of the American Dental Association"},{"issue":"6","key":"4815_CR21","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1038\/s41418-019-0470-y","volume":"27","author":"Y Santin","year":"2020","unstructured":"Santin, Y., et al. (2020). Mitochondrial 4-HNE derived from MAO-A promotes mitoCa2+ overload in chronic postischemic cardiac remodeling. Cell Death & Differentiation, 27(6), 1907\u20131923.","journal-title":"Cell Death & Differentiation"},{"key":"4815_CR22","doi-asserted-by":"publisher","first-page":"111525","DOI":"10.1016\/j.biopha.2021.111525","volume":"139","author":"A Pathania","year":"2021","unstructured":"Pathania, A., Kumar, R., & Sandhir, R. (2021). Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson\u2019s disease model. Biomedicine & Pharmacotherapy, 139, 111525.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"9","key":"4815_CR23","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1111\/bcp.13651","volume":"84","author":"CD Binde","year":"2018","unstructured":"Binde, C. D., et al. (2018). A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson\u2019s disease. British Journal of Clinical Pharmacology, 84(9), 1917\u20131927.","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"4815_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2174\/1386207323666200220115154","volume":"23","author":"BE Aksoz","year":"2020","unstructured":"Aksoz, B. E., & Aksoz, E. (2020). Vital role of monoamine oxidases and cholinesterases in central nervous system drug research: A sharp dissection of the pathophysiology. Combinatorial Chemistry & High Throughput Screening, 23(9), 877\u2013886.","journal-title":"Combinatorial Chemistry & High Throughput Screening"},{"issue":"8","key":"4815_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrn1728","volume":"6","author":"W L\u00f6scher","year":"2005","unstructured":"L\u00f6scher, W., & Potschka, H. (2005). Drug resistance in brain diseases and the role of drug efflux transporters. Nature Reviews Neuroscience, 6(8), 591\u2013602.","journal-title":"Nature Reviews Neuroscience"},{"issue":"47","key":"4815_CR26","doi-asserted-by":"publisher","first-page":"6478","DOI":"10.1002\/ejoc.202100857","volume":"2021","author":"OO Grygorenko","year":"2021","unstructured":"Grygorenko, O. O., Volochnyuk, D. M., & Vashchenko, B. V. (2021). Emerging building blocks for medicinal chemistry: Recent synthetic advances. European Journal of Organic Chemistry, 2021(47), 6478\u20136510.","journal-title":"European Journal of Organic Chemistry"},{"issue":"7","key":"4815_CR27","first-page":"2277","volume":"3","author":"S Haider","year":"2014","unstructured":"Haider, S., et al. (2014). Emerging pharmaceutical applications of piperidine, pyrrolidine and its derivatives. World Journal of Pharmaceutical Research, 3(7), 2277\u20137105.","journal-title":"World Journal of Pharmaceutical Research"},{"issue":"1","key":"4815_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acschemneuro.1c00435","volume":"13","author":"K Szczepa\u0144ska","year":"2021","unstructured":"Szczepa\u0144ska, K., et al. (2021). Structural and molecular insight into piperazine and piperidine derivatives as histamine H3 and sigma-1 receptor antagonists with promising antinociceptive properties. ACS Chemical Neuroscience, 13(1), 1\u201315.","journal-title":"ACS Chemical Neuroscience"},{"issue":"11","key":"4815_CR29","doi-asserted-by":"publisher","first-page":"e202200238","DOI":"10.1002\/slct.202200238","volume":"7","author":"NH Nasab","year":"2022","unstructured":"Nasab, N. H., et al. (2022). Coumarin-chalcones generated from 3-acetylcoumarin as a promising agent: Synthesis and pharmacological properties. ChemistrySelect, 7(11), e202200238.","journal-title":"ChemistrySelect"},{"issue":"14","key":"4815_CR30","doi-asserted-by":"publisher","first-page":"6791","DOI":"10.1021\/acs.jmedchem.6b00562","volume":"59","author":"L Pisani","year":"2016","unstructured":"Pisani, L., et al. (2016). Exploring basic tail modifications of coumarin-based dual acetylcholinesterase-monoamine oxidase B inhibitors: Identification of water-soluble, brain-permeant neuroprotective multitarget agents. Journal of Medicinal Chemistry, 59(14), 6791\u20136806.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"4815_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-78782-5","volume":"10","author":"JH Heo","year":"2020","unstructured":"Heo, J. H., et al. (2020). Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg. Scientific Reports, 10(1), 1\u201311.","journal-title":"Scientific Reports"},{"key":"4815_CR32","doi-asserted-by":"publisher","first-page":"131139","DOI":"10.1016\/j.molstruc.2021.131139","volume":"1246","author":"FS Aljohani","year":"2021","unstructured":"Aljohani, F. S., et al. (2021). Structural inspection for novel Pd (II), VO (II), Zn (II) and Cr (III)-azomethine metal chelates: DNA interaction, biological screening and theoretical treatments. Journal of Molecular Structure, 1246, 131139.","journal-title":"Journal of Molecular Structure"},{"issue":"2","key":"4815_CR33","first-page":"1","volume":"34","author":"SA Ejaz","year":"2022","unstructured":"Ejaz, S. A., et al. (2022). Identification of N-(4-acetyl-4, 5-dihydro-5-(7, 8, 9-substituted-tetrazolo [1, 5-a]-quinolin-4-yl)-1, 3, 4-thiadiazol-2-yl) acetamide derivatives as potential caspase-3 inhibitors via detailed computational investigations. Structural Chemistry, 34(2), 1\u201314.","journal-title":"Structural Chemistry"},{"issue":"1","key":"4815_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11696-022-02460-1","volume":"77","author":"PA Mahesar","year":"2023","unstructured":"Mahesar, P. A., et al. (2023). Potential role of hydrazinyl 1, 2, 4-triazoles derivatives as acetylcholinesterase inhibitors: Synthesis, biological evaluation, kinetics mechanism and molecular docking and simulation studies. Chemical Papers, 77(1), 1\u201313.","journal-title":"Chemical Papers"},{"issue":"3","key":"4815_CR35","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20130013","volume":"453","author":"F Nachon","year":"2013","unstructured":"Nachon, F., et al. (2013). Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer\u2019s drugs targeting acetyl-and butyryl-cholinesterase. Biochemical Journal, 453(3), 393\u2013399.","journal-title":"Biochemical Journal"},{"issue":"2","key":"4815_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cbi.2006.06.002","volume":"162","author":"M Ahmed","year":"2006","unstructured":"Ahmed, M., et al. (2006). Inhibition of two different cholinesterases by tacrine. Chemico-Biological Interactions, 162(2), 165\u2013171.","journal-title":"Chemico-Biological Interactions"},{"issue":"4","key":"4815_CR37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0306-4522(02)00351-2","volume":"114","author":"S Son","year":"2002","unstructured":"Son, S. (2002). Crystal structure of human monoamine oxidase A. Neuroscience, 114(4), 825\u2013835.","journal-title":"Neuroscience"},{"issue":"23","key":"4815_CR38","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"C Binda","year":"2007","unstructured":"Binda, C., et al. (2007). Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: Safinamide and coumarin analogs. Journal of Medicinal Chemistry, 50(23), 5848\u20135852.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"4815_CR39","doi-asserted-by":"publisher","first-page":"6404","DOI":"10.1038\/s41598-022-10253-5","volume":"12","author":"M Aziz","year":"2022","unstructured":"Aziz, M., et al. (2022). Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach. Scientific Reports, 12(1), 6404.","journal-title":"Scientific Reports"},{"issue":"12","key":"4815_CR40","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1007\/s12010-022-04083-4","volume":"194","author":"SA Ejaz","year":"2022","unstructured":"Ejaz, S. A., et al. (2022). In silico prospects and therapeutic applications of ouabagenin and hydroxylated corticosteroid analogues in the treatment of lung cancer. Applied Biochemistry and Biotechnology, 194(12), 6106\u20136125.","journal-title":"Applied Biochemistry and Biotechnology"},{"issue":"13","key":"4815_CR41","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.3390\/molecules27134098","volume":"27","author":"M Aziz","year":"2022","unstructured":"Aziz, M., et al. (2022). Deep learning and structure-based virtual screening for drug discovery against NEK7: A novel target for the treatment of cancer. Molecules, 27(13), 4098.","journal-title":"Molecules"},{"issue":"3\u20134","key":"4815_CR42","first-page":"1","volume":"22","author":"SA Ejaz","year":"2022","unstructured":"Ejaz, S. A., et al. (2022). 4-Phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: DFTs, 3D-QSAR, ADMET, and molecular dynamics simulation. Neurodegenerative Diseases, 22(3\u20134), 1\u201317.","journal-title":"Neurodegenerative Diseases"},{"issue":"11","key":"4815_CR43","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/biom12111696","volume":"12","author":"A Ahmed","year":"2022","unstructured":"Ahmed, A., et al. (2022). Design, synthesis, kinetic analysis and pharmacophore-directed discovery of 3-ethylaniline hybrid imino-thiazolidinone as potential inhibitor of carbonic anhydrase II: An emerging biological target for treatment of cancer. Biomolecules, 12(11), 1696.","journal-title":"Biomolecules"},{"issue":"79","key":"4815_CR44","doi-asserted-by":"publisher","first-page":"64404","DOI":"10.1039\/C5RA12455G","volume":"5","author":"I Khan","year":"2015","unstructured":"Khan, I., et al. (2015). Investigation of quinoline-4-carboxylic acid as a highly potent scaffold for the development of alkaline phosphatase inhibitors: Synthesis, SAR analysis and molecular modelling studies. RSC advances, 5(79), 64404\u201364413.","journal-title":"RSC advances"},{"issue":"10","key":"4815_CR45","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1007\/s00044-022-02945-4","volume":"31","author":"SA Channar","year":"2022","unstructured":"Channar, S. A., et al. (2022). Exploring thiazole-linked thioureas using alkaline phosphatase assay, biochemical evaluation, computational analysis and structure\u2013activity relationship (SAR) studies. Medicinal Chemistry Research, 31(10), 1792\u20131802.","journal-title":"Medicinal Chemistry Research"},{"issue":"2","key":"4815_CR46","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0959-440X(02)00308-1","volume":"12","author":"T Hansson","year":"2002","unstructured":"Hansson, T., Oostenbrink, C., & van Gunsteren, W. (2002). Molecular dynamics simulations. Current opinion in structural biology, 12(2), 190\u2013196.","journal-title":"Current opinion in structural biology"},{"key":"4815_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.18433\/jpps32011","volume":"24","author":"S Deb","year":"2021","unstructured":"Deb, S., & Reeves, A. A. (2021). Simulation of remdesivir pharmacokinetics and its drug interactions. Journal of Pharmacy and Pharmaceutical Sciences., 24, 277\u2013291.","journal-title":"Journal of Pharmacy and Pharmaceutical Sciences."}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04815-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04815-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04815-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T15:17:00Z","timestamp":1732807020000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04815-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["4815"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04815-0","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"19 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors agreed for the publication of the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All the authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}